Diabetic Retinopathy: An Update on Treatment
Abstract
Diabetic retinopathy is a progressive disease that results from vascular injury due to chronic hyperglycemia. It is the leading cause of blindness in working-age adults in the US and is usually asymptomatic until late stages. Treatment with laser photocoagulation is effective at preventing severe vision loss; thus, diabetic patients should be referred for regular screening by an ophthalmologist. New inhibitors of vascular endothelial growth factor may provide targeted nonsurgical treatment to improve vision in diabetic retinopathy.
Keywords: Antiangiogenic therapy, Diabetic retinopathy, Intravitreal injection, Laser photocoagulation, Macular edema, Neovascularization, Retina, Vascular Endothelial Growth Factor, Vitrectomy
Funding: None.
Conflict of Interest: None.
Authorship: All authors participated in the preparation of the manuscript.
PII: S0002-9343(09)01006-7
doi:10.1016/j.amjmed.2009.09.020
© 2010 Elsevier Inc. All rights reserved.

